An interventional study of water vapor thermal therapy (Rezum) for prostate in Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms, sponsored by Helwan University. Completed at 1 site in Egypt. Open to male participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-06-27.
Sponsored by Helwan University · Not applicable, Interventional, and Treatment
This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treated by Rezūm and followed up for 4 years prior to evaluating clinical outcomes.
The investigators will conduct a retrospective study evaluating patients treated with water vapor thermal therapy (Rezūm therapy) for BPH and followed up for4 years. The primary objectives are to assess the long-term effectiveness and morbidity rates associated with the procedure. Data collected will include urinary symptom scores, sexual function, and any treatment-related complications.
783 studies on the registry are indexed under Prostatic Hyperplasia; 174 are open to participants now.
This study's enrollment of 86 is below the median of 97 across 593 interventional studies indexed under Prostatic Hyperplasia.
Browse Prostatic Hyperplasia studies →Helwan University is the lead sponsor of 69 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
patients had benign prostatic hyperplasia and treated by rezum procedure from 2 to 4 years included in the study
Procedure: water vapor thermal therapy (Rezum) for prostate
all patients underwent rezum therapy for bph are evaluated for its effectiveness for long period
Also known as: Prostate steam treatment (Rezum) for benign prostatic hyperplasia (BPH)
change in prostate volume
Prostate volume will be measured via transrectal ultrasound.
Time frame: 4 years
hange in International Prostate Symptom Score (IPSS)
IPSS is a questionnaire evaluating urinary symptoms. Scores ranging from 0 to 7 indicate mild symptoms, from 8 to 19 moderate symptoms, and from 20 to 35 severe symptoms.
Time frame: 4 years
international index of erectile function (IIEF)
IIEF is a questionnaire evaluating sexual function. Scores ranging from 5 to 7 indicate severe symptoms, 8 to 11 moderate symptoms, 12 to 16 mild to moderate symptoms, 17 to 21 mild symptoms, and 22 to 25 no erectile dysfunction
Time frame: 4 years
Change in Post-Void Residual Urine
Residual urine volume measured after urination using pelvic ultrasound.
Time frame: 4 years
Retreatment Rate Following Rezūm Therapy
Number of participants requiring additional treatment for BPH after Rezūm therapy.
Time frame: 4 years
complication rate
incidence of complications post procedure during follow-up
Time frame: 4 years
Plan to share: No — Patients are not permitted to post any of their personal information
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Helwan University